Claritas Pharmaceuticals, Inc. Share Price
Stocks
CLAZF
CA1806342061
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
10:46:04 27/02/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 53.68L 38.64L 33.3L 31.22L 28.5L 37Cr 53.86L 3.7Cr 1.45Cr 19Cr 1.45Cr 1.42Cr 62Cr | P/E 2019 |
-0.74x | P/E 2020 | 0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 62.88L 45.26L 39L 36.57L 33.38L 43Cr 63.08L 4.34Cr 1.69Cr 22Cr 1.7Cr 1.66Cr 72Cr | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
99.74% | Yield 2019 * |
-
| Yield 2020 | - |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.4 | |
| 10 years | 0 | 15.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CEO | Chief Executive Officer | 76 | 21/06/2017 |
Victoria Rudman
DFI | Director of Finance/CFO | 58 | 29/06/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CHM | Chairman | 76 | 18/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/10/21 | Buy | 1,18,000 | 0.3332% | |||
| 11/10/21 | Buy | 1,52,500 | 0.4307% | |||
| 11/10/21 | Buy | 24,500 | 0.0692% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 37 | ||
| -0.78% | -1.42% | +2.49% | +22.78% | 5.11TCr | ||
| -6.00% | -0.75% | +442.41% | +544.39% | 4.74TCr | ||
| -0.24% | +0.74% | +38.69% | +18.02% | 4.32TCr | ||
| -1.55% | -2.07% | +23.08% | +81.47% | 4.24TCr | ||
| -0.31% | -0.83% | +16.15% | +51.42% | 3.32TCr | ||
| -1.79% | -3.24% | +27.00% | +129.56% | 1.71TCr | ||
| -0.58% | -2.12% | - | - | 1.64TCr | ||
| -0.88% | -0.66% | +11.60% | +27.75% | 1.48TCr | ||
| -1.66% | -1.25% | +78.59% | +46.66% | 1.42TCr | ||
| Average | -1.38% | +0.06% | +80.00% | +115.26% | 2.8TCr | |
| Weighted average by Cap. | -1.74% | +0.35% | +98.85% | +137.44% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.12Cr -1.53Cr -1.32Cr -1.23Cr -1.13Cr -145.92Cr -2.13Cr -15Cr -5.71Cr -74Cr -5.73Cr -5.61Cr -244.23Cr | 42.1L 30.3L 26.11L 24.48L 22.35L 29Cr 42.23L 2.9Cr 1.13Cr 15Cr 1.14Cr 1.11Cr 48Cr |
| Net Debt | 7L 5L 4L 4L 4L 4.84Cr 7L 48.57L 18.95L 2.44Cr 19.02L 18.61L 8.11Cr | 9L 7L 6L 5L 5L 6.33Cr 9L 63.47L 24.76L 3.19Cr 24.86L 24.32L 11Cr |
Employees
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- CLAZF Stock
Select your edition
All financial news and data tailored to specific country editions
















